Keep pulling the thread on DJ Seo.
Neuralink's first product, Telepathy, is designed to enable a person who has lost the ability to command their body to control a computer cursor by thinking.
Neuralink's next product, Blindsight, is designed to enable individuals with total vision loss to see again, even if they have lost their eyes or optic nerve.
Neuralink has implanted its brain-computer interface in 25 human participants.
A core part of Neuralink's strategy, influenced by Elon Musk, is building for scale from day one, including infrastructure for surgery, deployment, and device manufacturing.
Neuralink's long-term vision is for its robotic surgery to be as common as a LASIK surgery, deployable to millions or billions of people.
Neuralink is currently conducting preclinical testing on the next-generation version of its Blindsight device intended for human trials.
DJ Seo predicts Neuralink will begin human trials for its Blindsight device by the end of the current year.
DJ Seo believes the ultimate potential of brain-computer interface technology is to enable direct, uncompressed, high-fidelity, and multimodal transfer of concepts.
Neuralink is building a "neural foundational model" by fine-tuning state-of-the-art transformer networks with neural data from its participants.
Neuralink's Convoy team is developing assistive robotic devices that can be controlled by the company's brain implant.
The founding insight for Neuralink was the I/O bottleneck between human output and the capabilities of AI.
Elon Musk uses an "all green light schedule" as an engineering tool to determine the fastest possible project timeline by assuming no administrative, shipping, or legacy bottlenecks exist.